Prelude Therapeutics Inc
Prelude Therapeutics Inc (PRLD) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 156 transactions totaling $98.1M, demonstrating a bullish sentiment with $77.3M in net insider flow. The most recent transaction on Feb 4, 2026 involved a transaction of 837,000 shares valued at $0.
PRLD Insider Activity Summary
Who Is Buying PRLD Stock?
No significant insider buying has been recorded for PRLD in the recent period.
Who Is Selling PRLD Stock?
No significant insider selling has been recorded for PRLD in the recent period.
Is Prelude Therapeutics Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PRLD is bullish with an Insider Alignment Score of 89/100 and a net flow of $77.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PRLD Frequently Asked Questions
Understanding PRLD Insider Activity
Insider trading at Prelude Therapeutics Inc (PRLD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading PRLD stock, having executed 156 transactions in the past 90 days. The most active insider is Bros. Advisors (gp) Llc Baker (Executive), who has made 8 transactions totaling $30.0M.
Related Tools
Track Prelude Therapeutics Inc Insider Activity
Get notified when executives and directors at PRLD file new Form 4 transactions